Investor Presentation - August 2026

August 4, 2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Compliance & Legal Regulatory Listing & Compliance Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra East, Mumbai 400 051 Stock Code: 543233 Stock Symbol: CHEMCON Dear Sir/Madam, Sub: Investor Presentation Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing obligations and Disclosure Requirements), Regulations, 2015, please find enclose herewith the “Investor Presentation” for August 2026. The aforementioned presentation is also being uploaded on the Company’s website at www.cscpl.com. We request you to take the above on your records. Thanking you, Yours faithfully, For Chemcon Speciality Chemicals Limited Shahilkumar Kapatel Company Secretary & Compliance Officer Membership No.: A52211 Chemcon Speciality Chemicals Limited Investor Presentation – August 2026 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Chemcon Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Q1 FY27 Performance Highlights Q1 FY27 Performance Highlights “We are pleased to report a strong start to FY27, with the Company reporting quarterly revenue of ₹ 66 crore, reflecting healthy growth and a improvement in overall business performance. The quarter's performance was primarily driven by improved realizations across our product portfolio and steady demand across several key product categories. Our Organic Chemicals business witnessed a notable improvement during the quarter, driven by improved realizations across key products, including HMDS, CMIC, Bromobenzene and 2-Bromo. While pricing pressure from global competition particularly imports from China, continue to persist in select products, the overall operating environment remained favorable compared to the previous year, supporting better profitability and business performance. The Inorganic Chemicals segment also recorded a stable performance, aided by improved market conditions and improved demand on a year-on- year basis. Although geopolitical developments and volatility in crude oil markets continue to create uncertainty, the business delivered a meaningful recovery over the corresponding period last year. Looking ahead, we remain optimistic about our growth prospects, supported by improving realizations, encouraging traction across our newer product portfolio, and strengthening customer engagement across key end-user industries. While global macroeconomic conditions and geopolitical developments continue to present uncertainties, we believe our diversified product portfolio, expanding manufacturing capabilities position us well to deliver sustainable and profitable growth in the coming quarters.” Mr. Kamal Aggarwal, Chairman & Managing Director Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides 4 Financial Highlights Revenue from EBITDA (Rs. Cr) PAT (Rs. Cr) Operations (Rs. Cr) 75.4 15.4 11.0 66.5 53.5 8.9 6.4 6.4 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 3,497 Others 6% 5% 12% Export 30% 31% 15% 24% 13% 47% Inorganic Chemicals 1,972 2,098 2,066 Inorganic Chemicals 762 830 Domestic 70% 69% Organic Chemicals 79% 71% 75% Organic Chemicals 1,336 1,525 1,236 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides Export data are inclusive of Deemed Exports 5 Profit & Loss Statement Particulars (Rs. Crs) Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Q-o-Q FY26 Revenuefrom Operations 66.5 53.5 24% 75.4 -12% 240.0 Cost of Goods Sold 36.9 31.5 52.4 155.9 Employee Cost 5.7 5.0 5.3 20.1 Other Expenses 8.5 9.3 8.8 33.9 EBITDA 15.4 7.7 98% 8.9 74% 30.2 EBITDA Margin 23.2% 14.5% 11.8% 12.6% Other Income 3.7 3.7 4.2 15.5 Depreciation 3.7 2.7 3.2 11.6 EBIT 15.4 8.7 9.8 34.1 Finance Cost 0.8 0.3 1.0 2.1 Profit before Tax 14.6 8.4 8.8 32.0 Tax 3.6 2.0 2.4 8.4 PAT 11.0 6.4 72% 6.4 72% 23.6 PAT Margin % 16.5% 11.9% 8.4% 9.8% Basic EPS 2.99 1.74 1.74 6.44 Company Overview Company Snapshot Incorporated in 1988 Only Manufacturer of HMDS in India Manufacturer of Speciality Chemicals 3rd Largest Manufacturer of HMDS Worldwide An ISO 9001:2015 and ISO 14001:2015 Certified Company Largest Manufacturer of CMIC worldwide Business Verticals: Organic Chemicals and Inorganic Chemicals Only Manufacturer of Zinc Bromide in India 2 Manufacturing Facilities at Vadodara, Gujarat (Manjusar and Gothada ) Largest Manufacturer of Calcium 10 Operational Units, 6 Owned Bromide in India Warehouses Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides 8 Evolution FY89 FY95-98 FY01-03 FY05 FY14-16 FY17 » Company was » First sale of few » Commenced HMDS » First export shipment of » First sale of CMIC » First sale of Calcium incorporated as chemical products Business in 2001 HMDS Bromide (Powder) Gujarat Quinone • Pyridine » First sale of Calcium Private Limited Hydrobromide » Discontinued few » Amalgamation of Chemcon Bromide (Solution) » First sale of Sodium • Para Nitro Benzyl products due to Engineers Private Limited Bromide (Solution) Bromide lower demand with Gujarat Quinone » First sale of Zinc • Methyl Iodide Private Limited; name Bromide (Solution) • GA-1 changed to “Chemcon Speciality Chemicals Private Limited” FY18 FY19 FY20-21 FY22–24 FY25 FY26 » Added new product, » Increase in annual » Increase in annual » Increase in CMIC & » Acquired Shivam » Increase in HMDS 2 Bromo with a capacity installed production installed production TMCS Capacity by Petrochem Industries Capacity by of 600 MTPA capacity for capacity for CMIC from commissioning of plant through slump sale commissioning of plant • CMIC from 600 to 1,200 MT [Showing first 8,000 characters — download PDF for full document]